Mechanistic Investigation of β-Galactosidase-Activated MR Contrast Agents
Abstract
We report a mechanistic investigation of an isomeric series of β-galactosidase-activated magnetic resonance contrast agents. Our strategy focuses on the synthesis of macrocyclic caged-complexes that coordinatively saturate a chelated lanthanide. Enzyme cleavage of the complex results in an open coordination site available for water that creates a detectable MR contrast agent. The complexes consist of a DO3A Gd(III) chelator modified with a galactopyranose at the N-10 position of the macrocycle. We observed significant differences in relaxometric properties and coordination geometry that can be correlated to subtle variations of the linker between the macrocycle and the galactopyranose. After synthesis and purification of the R, S, and racemic mixtures of complexes 1 and 3 and measurement of the hydration number, water residence lifetime, and longitudinal relaxation rates, we propose mechanisms for water exclusion from the lanthanide in the precleavage state. While the stereochemistry of the linker does not influence the agents' properties, the mechanism of water exclusion for each isomer is significantly influenced by the position of modification. Data for one series with a methyl group substituted on the sugar-macrocycle linker at the α-position suggests a steric mechanism where the galactopyranose sugar blocks water from the Gd(III) center. In contrast, our observations for a second series with methyl substitution at the β position of the sugar-macrocycle linker are consistent with a mechanism in which a bidentate anion occupies two available coordination sites of Gd(III) in the precleavage state.
Additional Information
© 2008 American Chemical Society. Received May 8, 2007. Publication Date (Web): December 12, 2007. We thank Keith MacRenaris for assistance with ICP−MS measurements and Dr. Matthew Hartings for figures in the Table of Contents. This work was supported by NIH Grant 5 U54 CA90810, NIH Grant RO1 A147003, and DOD Grant DAMD 17-02-1-0693.Attached Files
Supplemental Material - ic700888w-file002.pdf
Supplemental Material - ic700888w-file004.cif
Supplemental Material - ic700888w-file005.cif
Files
Name | Size | Download all |
---|---|---|
md5:6b8ca7c25bbc6d6074989fe4fb067a44
|
19.6 kB | Download |
md5:610f7f791f75175d84638ed5b451c503
|
3.1 MB | Preview Download |
md5:439f08bee1013a2846f32c753f2d8424
|
17.3 kB | Download |
Additional details
- Alternative title
- Mechanistic investigation of beta-galactosidase-activated MR contrast agents
- Eprint ID
- 77812
- Resolver ID
- CaltechAUTHORS:20170526-110756449
- NIH
- 5 U54 CA90810
- NIH
- RO1 A147003
- Department of Defense
- DAMD 17-02-1-0693
- Created
-
2017-05-26Created from EPrint's datestamp field
- Updated
-
2021-11-15Created from EPrint's last_modified field